Headquartered in Durham, NC Fiscal year ends December NASDAQ: BVS bioventus.com
Bioventus Inc. is a medical device company that delivers clinically proven, cost-effective products focused on active healing. The company operates through three business segments: Pain Treatments, which includes hyaluronic acid viscosupplementation therapies such as Durolane for joint pain; Surgical Solutions, which encompasses Ultrasonics capital equipment and related products used in surgical procedures; and Restorative Therapies, which features the EXOGEN Bone Stimulation System for bone healing. Bioventus serves physicians and healthcare providers globally, with the majority of its revenue generated in the United States. The company trades on Nasdaq under the ticker BVS and has Class A and Class B common stock structures. Updated
Consumer confidence is breaking down in a way investors have not seen in years. The University of Michigan Consumer Sentiment Index landed at 53.3 in March 2026, sitting below the 60 recessionary…
Bioventus Inc. is a medical device company that delivers clinically proven, cost-effective products focused on active healing.
The Wall Street consensus 12-month price target for BVS is $17.60.
